Deltagen Inc. reported unaudited consolidated earnings results for the second quarter ended June 30, 2012. For the period, the company reported revenue of $220,000. The revenues in the second quarter of 2012 were attributable primarily to license fees associated with the provision of knockout mice and related phenotypic data pursuant to orders placed by customers under the company's DeltaOne program.

For the quarter, the company reported loss from operations of $1,264,000 and net loss of $1,263,000. Cash flows from operating activities were negative at $361,000.